References
McArthur MA, Kalu SU, Foulks AR, Aly AM, Jain SK, Patel JA. Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy. Pediatr Infect Dis J. 2009;28(12):1127–9.
Chaubey SK, Sinha AK, Phillips E, Russell DB, Falhammar H. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sex Health. 2009;6(3):254–7.
Darunavir (Prezista®) product Information. Janssen Pharmaceuticals. Accessed 23 May 2017.
Darunavir/Cobicistat (Prezcobix®) product monograph. Janssen Pharmaceuticals. Accessed 11 Aug 2017.
Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, Badley AD. Blockade of HERG channels by HIV protease inhibitors. Lancet. 2005;365(9460):682–6.
Ogunmola OJ, Oladosu YO, Olamoyegun MA. QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs. Ann Afr Med. 2015;14(4):169–76.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
None.
Conflict of interest
On the behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Gonzales Zamora, J.A., Espinoza, L.A. Sinus bradycardia induced by darunavir-ritonavir in a patient with acquired immunodeficiency syndrome. Infection 45, 721–723 (2017). https://doi.org/10.1007/s15010-017-1065-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-017-1065-5